Purple Biotech Announces ADS Ratio Change
Company Announcements

Purple Biotech Announces ADS Ratio Change

Purple Biotech (PPBT) has released an update.

Purple Biotech Ltd. has announced a change in the ratio of its American Depositary Shares (ADSs) to regain compliance with Nasdaq’s minimum bid price requirement. Effective September 17, 2024, the new ratio will equate one ADS to two hundred ordinary shares, essentially a one-for-twenty reverse ADS split. This adjustment is expected to proportionally increase the trading price of the Company’s ADSs on Nasdaq, with no effect on its ordinary shares traded on The Tel Aviv Stock Exchange.

For further insights into PPBT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskPurple Biotech Unveils Promising Biomarker for Cancer Therapy
TheFlyPurple Biotech identifies potential new serum biomarker for CM24
Brian AndersonPPBT Upcoming Earnings Report: What to Expect?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App